These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1013177)

  • 1. Binding of an opiate, levorphanol, to intact neuroblastoma cells in continuous culture.
    North-Root H; Martin DW; Toliver AP
    Physiol Chem Phys; 1976; 8(3):221-8. PubMed ID: 1013177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for nuclear sites of stereospecific opiate binding in neuroblastoma cells in continuous culture.
    North-Root H; Martin DW; Toliver AP
    Physiol Chem Phys; 1976; 8(5):437-46. PubMed ID: 196299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain.
    Goldstein A; Lowney LI; Pal BK
    Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1742-7. PubMed ID: 5288759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity.
    Martin JR; Takemori AE
    J Pharmacol Exp Ther; 1987 Apr; 241(1):48-55. PubMed ID: 3572795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone binding at nonopiate receptor binding sites.
    Ciofalo FR
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):419-30. PubMed ID: 451332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific binding of morphine to phosphatidyl serine.
    Abood LG; Host WP
    Psychopharmacol Commun; 1975; 1(1):29-35. PubMed ID: 1241450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process.
    Law PY; Hom DS; Loh HH
    Mol Pharmacol; 1982 Jul; 22(1):1-4. PubMed ID: 6126803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolipids and opiate action.
    McLawhon RW; Schoon GS; Dawson G
    Eur J Cell Biol; 1981 Oct; 25(2):353-8. PubMed ID: 6277638
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation of opiate action in neuroblastoma N18TG2 cells by lipid incorporation.
    Law PY; Nicksic TD; O'Rourke MA; Koehler JE; Herz A; Loh HH
    Mol Pharmacol; 1982 Mar; 21(2):492-502. PubMed ID: 6285174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis.
    Makman MH; Bilfinger TV; Stefano GB
    J Immunol; 1995 Feb; 154(3):1323-30. PubMed ID: 7822801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saturable binding of dihydromorphine and naloxone to rat brain tissue in vitro.
    Lee CY; Akera T; Stolman S; Brody TM
    J Pharmacol Exp Ther; 1975 Sep; 194(3):583-92. PubMed ID: 1159633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiates and thermoregulation in mice. IV. Tolerance and cross-tolerance.
    Rosow CE; Miller JM; Poulsen-Burke J; Cochin J
    J Pharmacol Exp Ther; 1982 Dec; 223(3):702-8. PubMed ID: 7143233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term morphine treatment enhances proteasome-dependent degradation of G beta in human neuroblastoma SH-SY5Y cells: correlation with onset of adenylate cyclase sensitization.
    Moulédous L; Neasta J; Uttenweiler-Joseph S; Stella A; Matondo M; Corbani M; Monsarrat B; Meunier JC
    Mol Pharmacol; 2005 Aug; 68(2):467-76. PubMed ID: 15901846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
    Zadina JE; Chang SL; Ge LJ; Kastin AJ
    J Pharmacol Exp Ther; 1993 Apr; 265(1):254-62. PubMed ID: 8097244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY; Bergsbaken C
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
    Fisher SK
    Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cyclic adenosine 3':5'-monophosphate-binding protein in N-18 mouse neuroblastoma cells.
    Liu AY; Fiske WW; Chen KY
    Cancer Res; 1980 Nov; 40(11):4100-8. PubMed ID: 6258772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
    Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
    Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
    Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth.
    Grellier P; De Galle B; Babajko S
    Cancer Res; 1998 Apr; 58(8):1670-6. PubMed ID: 9563481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.